Search alternatives:
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
derived therapeutics » targeted therapeutics (Expand Search), novel therapeutics (Expand Search), based therapeutics (Expand Search)
host resistance » plant resistance (Expand Search)
decrease host » decreases short (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
derived therapeutics » targeted therapeutics (Expand Search), novel therapeutics (Expand Search), based therapeutics (Expand Search)
host resistance » plant resistance (Expand Search)
decrease host » decreases short (Expand Search)
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
DataSheet_1_Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics.pdf
Published 2024“…Background<p>Adrenocortical carcinoma (ACC) is an aggressive endocrine malignancy with limited therapeutic options. Treating advanced ACC with mitotane, the cornerstone therapy, remains challenging, thus underscoring the significance to predict mitotane response prior to treatment and seek other effective therapeutic strategies.…”
-
95
-
96
-
97
-
98
-
99
-
100